InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Imiquimod (R837) | Intratumoral combination therapy with poly(I:C) and resiquimod synergisticall... | 2021 | J Immunother Cancer | Anfra C. et al. | DOI: 10.1136/jitc-2021-002408 |
| QUANTI-Luc™: Luciferase Detection Reagent | Intratumoral combination therapy with poly(I:C) and resiquimod synergisticall... | 2021 | J Immunother Cancer | Anfra C. et al. | DOI: 10.1136/jitc-2021-002408 |
| Poly(I:C) LMW | Intrauterine immunizations trigger antigen-specific mucosal and systemic immu... | 2021 | Vaccine | Choudhary P. et al. | DOI: 10.1016/j.vaccine.2021.08.080 |
| IL-1α & IL-1β Reporter HEK 293 Cells | Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients wit... | 2021 | Cell Discov. | Xue L. et al. | DOI: 10.1038/s41421-021-00299-6 |
| IL-6 Reporter HEK 293 Cells | Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients wit... | 2021 | Cell Discov. | Xue L. et al. | DOI: 10.1038/s41421-021-00299-6 |
| 3'3'-cGAMP | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
| ODN 1585 - TLR9 ligand | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
| R848 (Resiquimod) | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
| ODN 2006 (ODN 7909) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
| Human TLR9 Reporter HEK293 Cells (NF-κB) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
| ODN TTAGGG (A151) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
| CPPD Crystals | Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice. | 2021 | Nutrients | Oliviero F. et al. | DOI: 10.3390/nu13030929 |
| CPPD Crystals | Chondrocytes From Osteoarthritic and Chondrocalcinosis Cartilage Represent Di... | 2021 | Front Cell Dev Biol. | Meyer F. et al. | DOI: 10.3389/fcell.2021.622287 |
| Primocin® | Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and support... | 2021 | PLoS Pathog | Bagayoko S. et al. | DOI: 10.1371/journal.ppat.1009927 |
| HEK-Blue™ Detection | Deimmunization of flagellin for repeated administration as a vaccine adjuvant. | 2021 | NPJ Vaccines | Khim K. et al. | DOI: 10.1038/s41541-021-00379-4 |
| Human TLR5 Reporter HEK293 Cells (NF-κB) | Deimmunization of flagellin for repeated administration as a vaccine adjuvant. | 2021 | NPJ Vaccines | Khim K. et al. | DOI: 10.1038/s41541-021-00379-4 |
| Peptide M / Agarose | IgA anti-citrullinated protein antibodies (IgA ACPA) are associated with flar... | 2021 | Rheumatology (Oxford) | Sokolova M.V. et al. | DOI: 10.1093/rheumatology/keab585 |
| Anti-hTLR2 Detection and Neutralizing mAb | Phenol-soluble modulins α are major virulence factors of Staphylococcus aureu... | 2021 | Virulence | Damour A. et al. | DOI: 10.1080/21505594.2021.1975909 |
| Poly(I:C) LMW | KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Ta... | 2021 | J Immunol. | Li Q. et al. | DOI: 10.4049/jimmunol.2100342 |
| Poly(I:C) HMW | KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Ta... | 2021 | J Immunol. | Li Q. et al. | DOI: 10.4049/jimmunol.2100342 |